Pharmac is proposing new treatment options for melanoma, with the best case scenario looking promising for patients

Consultation's open on whether to increase access to nivolumab and ipilimumab for treating stage 3b and 4 melanoma, from May.

It's already available for some melanoma and kidney cancer patients, however, use pre-surgery can lower the chance of cancer returning.

Clinical oncologist Dr Rosalie Stephens says someone could effectively be cured after just 6 weeks of treatment.